Intestinal pharmacokinetics of resveratrol and regulatory effects of resveratrol metabolites on gut barrier and gut microbiota

Bode, 2013, In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota, American Journal of Clinical Nutrition, 97, 295, 10.3945/ajcn.112.049379 Boocock, 2007, Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent, Cancer Epidemiology, Biomarkers and Prevention, 16, 1246, 10.1158/1055-9965.EPI-07-0022 Boocock, 2007, Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography, Journal of Chromatography. B: Analytical Technologies in the Biomedical and Life Sciences, 848, 182, 10.1016/j.jchromb.2006.10.017 Brown, 2014, Less is more for cancer chemoprevention: evidence of a non-linear dose response for the protective effects of resveratrol, Mutagenesis, 29, 524 Canfora, 2019, Gut microbial metabolites in obesity, NAFLD and T2DM, Nature Reviews: Endocrinology, 15, 261 Carpéné, 2019, Resveratrol Anti-Obesity Effects: Rapid Inhibition of Adipocyte Glucose Utilization, Antioxidants (Basel), 8, 74, 10.3390/antiox8030074 Carrasco-Pozo, 2013, Polyphenols protect the epithelial barrier function of Caco-2 cells exposed to indomethacin through the modulation of occludin and zonula occludens-1 expression, Journal of Agricultural and Food Chemistry, 61, 5291, 10.1021/jf400150p Courtois, 2017, In Vitro Glucuronidation and Sulfation of epsilon-Viniferin, a Resveratrol Dimer, in Humans and Rats, Molecules, 22, 10.3390/molecules22050733 Cuevas-González, 2020, Postbiotics and paraprobiotics: From concepts to applications, Food Research International, 136, 109502, 10.1016/j.foodres.2020.109502 Dos Santos, 2019, Effects of Quercetin and Resveratrol on in vitro Properties Related to the Functionality of Potentially Probiotic Lactobacillus Strains, Frontiers in Microbiology, 10, 2229, 10.3389/fmicb.2019.02229 Gribble, 2016, Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium, Annual Review of Physiology, 78, 277, 10.1146/annurev-physiol-021115-105439 Huang, 2019, Natural phenolic compounds potentiate hypoglycemia via inhibition of Dipeptidyl peptidase IV, Scientific Reports, 9, 15585, 10.1038/s41598-019-52088-7 Johansson, 2016, Immunological aspects of intestinal mucus and mucins, Nature Reviews: Immunology, 16, 639 Kolouchová, 2018, Resveratrol, pterostilbene, and baicalein: Plant-derived anti-biofilm agents, Folia Microbiologica, 63, 261, 10.1007/s12223-017-0549-0 Larrosa, 2009, Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model, Journal of Agricultural and Food Chemistry, 57, 2211, 10.1021/jf803638d Levey, 2009, A new equation to estimate glomerular filtration rate, Annals of International Medicine, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Li, 2017, Effect of the A-Type Linkage on the Pharmacokinetics and Intestinal Metabolism of Litchi Pericarp Oligomeric Procyanidins, Journal of Agricultural and Food Chemistry, 65, 1893, 10.1021/acs.jafc.7b00017 Luca, 2020, Bioactivity of dietary polyphenols: The role of metabolites, Critical Reviews in Food Science and Nutrition, 60, 626, 10.1080/10408398.2018.1546669 A., 2002, Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model, Pediatric Surgery International, 18, 586, 10.1007/s00383-002-0855-7 Mayangsari, 2018, Resveratrol enhances intestinal barrier function by ameliorating barrier disruption in Caco-2 cell monolayers, Journal of Functional Foods, 51, 39, 10.1016/j.jff.2018.10.009 Meng, 2020, Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review, Foods, 9, 340, 10.3390/foods9030340 Muzzio, 2012, Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs, Journal of Pharmaceutical and Biomedical Analysis, 59, 201, 10.1016/j.jpba.2011.10.023 Odenwald, 2017, The intestinal epithelial barrier: A therapeutic target?, Nature Review Gastroenterology Hepatology, 14, 9, 10.1038/nrgastro.2016.169 Patel, 2010, Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients, Cancer Research, 70, 7392, 10.1158/0008-5472.CAN-10-2027 Pickard, 2017, Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease, Immunological Reviews, 279, 70, 10.1111/imr.12567 Qiao, 2014, Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity, Food & function, 5, 1241, 10.1039/c3fo60630a Salla, 2020, Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs, Molecules, 25, 3849, 10.3390/molecules25173849 Shen, 2018, Reciprocal interactions between resveratrol and gut microbiota deepen our understanding of molecular mechanisms underlying its health benefits, Trends In Food Science & Technology, 81, 232, 10.1016/j.tifs.2018.09.026 Springer, 2019, Resveratrol and Its Human Metabolites-Effects on Metabolic Health and Obesity, Nutrients, 11, 143, 10.3390/nu11010143 Van Beers, 1995, Intestinal brush border glycohydrolases: Structure, function, and development, Critical Reviews in Biochemistry and Molecular Biology, 30, 197, 10.3109/10409239509085143 Walle, 2011, Bioavailability of resveratrol, Annals of the New York Academy of Sciences, 1215, 9, 10.1111/j.1749-6632.2010.05842.x Walle, 2004, High absorption but very low bioavailability of oral resveratrol in humans, Drug Metabolism And Disposition, 32, 1377, 10.1124/dmd.104.000885 Wan, 2016, Green tea polyphenol epigallocatechin-3-gallate improves epithelial barrier function by inducing the production of antimicrobial peptide pBD-1 and pBD-2 in monolayers of porcine intestinal epithelial IPEC-J2 cells, Molecular Nutrition and Food Research, 60, 1048, 10.1002/mnfr.201500992 Wang, 2020, Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota, Free Radical Biology and Medicine, 156, 83, 10.1016/j.freeradbiomed.2020.04.013 Wang, P., Li, D., Ke, W., Liang, D., Hu, X., & Chen, F. (2020). Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice. International Journal of Obesity (2005), 44(1), 213-225. Zhang, 2020, Dietary Supplementation of Foxtail Millet Ameliorates Colitis-Associated Colorectal Cancer in Mice via Activation of Gut Receptors and Suppression of the STAT3 Pathway, Nutrients, 12, 2367, 10.3390/nu12082367 Zhang, 2019, Intestinal metabolism of baicalein after oral administration in mice: Pharmacokinetics and mechanisms, Journal of Functional Foods, 54, 53, 10.1016/j.jff.2018.12.037 Zhao, 2019, Resveratroloside Alleviates Postprandial Hyperglycemia in Diabetic Mice by Competitively Inhibiting alpha-Glucosidase, Journal of Agricultural and Food Chemistry, 67, 2886, 10.1021/acs.jafc.9b00455